IRIS
CENTONZE, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 139.280
AS - Asia 15.109
EU - Europa 10.920
SA - Sud America 2.325
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 61
OC - Oceania 44
AN - Antartide 1
Totale 167.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 138.957
SG - Singapore 7.745
CN - Cina 2.578
BR - Brasile 1.989
IT - Italia 1.828
HK - Hong Kong 1.819
UA - Ucraina 1.807
DE - Germania 1.603
KR - Corea 1.536
IE - Irlanda 1.470
RU - Federazione Russa 812
GB - Regno Unito 704
SE - Svezia 660
VN - Vietnam 538
FR - Francia 524
FI - Finlandia 458
PL - Polonia 347
NL - Olanda 243
CA - Canada 177
IN - India 146
AR - Argentina 136
JP - Giappone 126
ID - Indonesia 109
MX - Messico 87
AT - Austria 73
BD - Bangladesh 72
ES - Italia 69
IQ - Iraq 69
ZA - Sudafrica 59
CZ - Repubblica Ceca 58
BE - Belgio 56
TR - Turchia 56
EU - Europa 50
EC - Ecuador 49
RO - Romania 41
UZ - Uzbekistan 40
AU - Australia 37
CL - Cile 36
IR - Iran 36
BG - Bulgaria 35
PY - Paraguay 30
CO - Colombia 26
MA - Marocco 25
SA - Arabia Saudita 24
LT - Lituania 23
KG - Kirghizistan 20
AE - Emirati Arabi Uniti 19
PE - Perù 19
UY - Uruguay 18
VE - Venezuela 18
KE - Kenya 17
DK - Danimarca 16
KZ - Kazakistan 16
PK - Pakistan 16
DM - Dominica 15
IL - Israele 15
PH - Filippine 15
CH - Svizzera 14
MY - Malesia 14
PT - Portogallo 13
TN - Tunisia 13
EG - Egitto 12
AZ - Azerbaigian 10
HR - Croazia 10
JO - Giordania 10
OM - Oman 10
TW - Taiwan 10
DZ - Algeria 9
GR - Grecia 9
DO - Repubblica Dominicana 8
LB - Libano 8
A2 - ???statistics.table.value.countryCode.A2??? 7
NO - Norvegia 7
NP - Nepal 7
RS - Serbia 7
AL - Albania 6
BN - Brunei Darussalam 6
HU - Ungheria 6
KH - Cambogia 6
TT - Trinidad e Tobago 6
CR - Costa Rica 5
HN - Honduras 5
JM - Giamaica 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
BH - Bahrain 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
NG - Nigeria 4
PA - Panama 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BO - Bolivia 3
BW - Botswana 3
EE - Estonia 3
GT - Guatemala 3
LV - Lettonia 3
MN - Mongolia 3
PS - Palestinian Territory 3
SV - El Salvador 3
Totale 167.851
Salva come PNG Salva come JPEG
Città #
Woodbridge 39.339
Wilmington 37.985
Houston 32.923
Fairfield 4.480
Ann Arbor 3.276
Singapore 3.028
Ashburn 2.169
Hong Kong 1.793
Seattle 1.789
Chandler 1.747
Jacksonville 1.592
Cambridge 1.534
Dublin 1.415
Beijing 1.066
Medford 1.025
Santa Clara 588
New York 567
Dearborn 561
Rome 493
Lawrence 486
The Dalles 463
Los Angeles 388
Dallas 360
Zhengzhou 348
Buffalo 308
Kraków 274
Hangzhou 269
Mülheim 241
San Diego 236
Council Bluffs 218
Menlo Park 199
Ho Chi Minh City 190
São Paulo 187
Norwalk 171
Milan 158
Munich 158
London 118
Chicago 111
Redwood City 107
Hanoi 105
Moscow 96
Guangzhou 90
Shanghai 90
San Mateo 85
Redondo Beach 83
Mountain View 80
Nuremberg 80
University Park 78
Jakarta 76
Falls Church 69
Tokyo 65
Seoul 64
Rio de Janeiro 63
Saint Petersburg 60
Brooklyn 58
Verona 58
San Francisco 56
Lappeenranta 55
Palo Alto 55
Toronto 55
Detroit 53
Hefei 53
Montreal 52
Nanjing 52
Belo Horizonte 50
Warsaw 50
Brussels 49
Helsinki 47
Brno 46
Mcallen 45
Columbus 44
Salt Lake City 44
Atlanta 43
Boardman 41
Denver 40
San Jose 40
Brasília 38
Chennai 38
Philadelphia 38
Kunming 36
Phoenix 34
Naples 33
Orem 33
Colorado Springs 32
Johannesburg 32
Poplar 32
Boston 31
Nanchang 31
Stockholm 30
Vienna 30
Elk Grove Village 29
Mexico City 27
Amsterdam 26
Center 26
Tashkent 26
Campinas 24
Porto Alegre 24
Curitiba 23
Tampa 23
Roebling 21
Totale 145.347
Salva come PNG Salva come JPEG
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 710
Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis 650
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 598
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 595
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 588
TRPV1 channels facilitate glutamate transmission in the striatum 586
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity 578
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 568
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 555
Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others? 554
Neurophysiology of synaptic functioning in multiple sclerosis 547
Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma 545
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 536
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 535
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 509
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum 507
KFLC Index utility in multiple sclerosis diagnosis: Further confirmation 506
miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation 503
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 500
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 495
Effects of postural exercises in patients with Parkinson's disease and Pisa syndrome: A pilot study 495
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 494
Budget Impact Analysis for Peginterferon Beta-1a In Relapsing Remitting Multiple Sclerosis In Italy 491
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 488
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 487
Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum 487
The cross-cultural adaptation and psychometric validation of the MSSS-88 for use in Italian patients with multiple sclerosis 487
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 486
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 485
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis 484
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 482
Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis 482
TRPV1 polymorphisms and risk of interferon β-induced flu-like syndrome in patients with relapsing-remitting multiple sclerosis 479
K Index in cerebrospinal fluid: a valid tool in multiple sclerosis diagnosis 471
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads 470
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 467
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 465
Subclinical central inflammation is risk for RIS and CIS conversion to MS 465
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 464
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 464
Muscarinic IPSPs in rat striatal cholinergic interneurones 461
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 461
Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study 459
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 458
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 457
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 457
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 456
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 455
Treatment decisions for patients with active multiple sclerosis 455
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 455
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis 453
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 451
Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells 450
Placebo effects in a multiple sclerosis spasticity enriched clinical trial with the oromucosal cannabinoid spray (THC/CBD): dimension and possible causes 450
A Substrate Trapping Mutant Form of Striatal-Enriched Protein Tyrosine Phosphatase Prevents Amphetamine-Induced Stereotypies and Long-Term Potentiation in the Striatum 449
Abnormal brain lateralization and connectivity in schizophrenia 449
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 449
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 448
TRPV1 channels regulate cortical excitability in humans 448
Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors 448
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 447
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 447
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 446
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 446
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 446
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 446
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 445
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 445
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 444
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 444
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 444
Determination of κFLC and κ Index in cerebrospinal fluid: a valid alternative to assess intrathecal immunoglobulin synthesis 444
Interleukin-1β Promotes Long-Term Potentiation in Patients with Multiple Sclerosis 442
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis 442
Synaptic transmission in the striatum: from plasticity to neurodegeneration 441
Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes 440
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 440
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis 440
Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management 440
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 439
Disability in multiple sclerosis: When synaptic long-term potentiation fails 439
Transcranial direct current stimulation (tdcs) does not produce acute urodynamic changes 438
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 438
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 437
Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis 436
Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis 435
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 435
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis 434
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 434
Phase III dose-comparison study of glatiramer acetate for multiple sclerosis 433
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis 433
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study 433
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 433
D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801 431
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study 430
Linking synaptopathy and gray matter damage in multiple sclerosis 430
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 429
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 429
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 429
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 428
Totale 47.359
Salva come PNG Salva come JPEG
Categoria #
all - tutte 387.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 387.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110.360 0 0 0 0 0 2.312 3.544 2.204 626 471 871 332
2021/20224.744 193 338 187 240 107 672 204 201 428 542 225 1.407
2022/20235.771 746 378 291 614 344 1.503 553 300 398 42 446 156
2023/20241.881 260 72 136 110 161 439 156 98 35 64 33 317
2024/202513.550 357 2.722 1.252 656 478 1.050 1.003 509 1.048 1.087 1.897 1.491
2025/20268.695 1.514 1.083 2.292 1.306 2.054 446 0 0 0 0 0 0
Totale 169.712